BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 18, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 18, 2018
View Archived Issues
Astellas grants Cardurion license for PDE9 inhibitor with potential in heart failure
Read More
Merck & Co. initiates two phase III studies for PCV-15
Read More
FDA expands approval of Vonvendi to include perioperative management of bleeding in adults with VWD
Read More
Akcea and Ionis complete inotersen licensing transaction
Read More
Enanta Pharmaceuticals unveils new compound for HBV infection
Read More
Exosomal miRNAs linked to radioresistant lung adenocarcinoma
Read More
Theralase updates results from phase Ib study of TLD-1433 in nonmuscle invasive bladder cancer
Read More
DSMB recommends continuation of phase I/IIa study of VBI-1901 in recurrent GBM
Read More
FDA approves Tavalisse for chronic ITP
Read More
Targeting NLRP3 shows promise for NASH and fibrosis
Read More
Third endometriosis program enters phase I under Evotec and Bayer alliance
Read More
Anavex to initiate phase II trial of ANAVEX2-73 in Parkinson's disease dementia
Read More
EPL-1410 demonstrates potential as immune-oncology therapeutic in preclinical models
Read More
FDA grants orphan drug designation to KL-1333 for inherited mitochondrial respiratory chain diseases
Read More
Asahi Kasei Pharma initates phase III study of isavuconazole for deep-seated mycosis
Read More
BioAtla describes activity of anti-ROR2 antibody-drug conjugate BA-3021
Read More
GlaxoSmithKline patents novel TrpV4 antagonists
Read More
Mission Therapeutics divulges new USP30 inhibitors
Read More
Mironid identifies novel PDE4 activators
Read More
Pfizer launches Besponsa in Japan
Read More
Bayer patents novel IRAK-4 inhibitors
Read More
FDA approves Crysvita for X-linked hypophosphatemia in children and adults
Read More
New compounds for asthma presented by Sichuan Haisco Pharmaceutical
Read More
